olaparib,abiraterone,talazoparib,enzalutamide
merck,astellas,astrazeneca,pfizer
['talapro-2', 'propel', 'prostate', 'talzenna', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'lynparza', '$pfe', '$mrk', '$azn']
#gu23 discussant slams $pfe talzenna all-comers claim, just as $azn $mrk lynparza shows what could go wrong. my take on talapro-2 &amp; propel data in 1l prostate cancer, via -&gt; 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.